Journal of Medicinal Chemistry p. 1191 - 1200 (1992)
Update date:2022-07-30
Topics:
Harper, Richard W.
Herron, David K.
Bollinger, Nancy G.
Sawyer, J. Scott
Baldwin, Ronald F.
et al.
A hypothetical model for receptor binding of leukotriene D4 (LTD4) was deduced from conformational analysis of LTD4 and from the structure-activity relationships (SAR) of known LTD4 receptor antagonists.A new structural series of LTD4 receptor antagonists exemplified by 5-<4-(4-phenylbutoxy)phenyl>-2-<4-(tetrazol-5-yl)butyl>-2H-tetrazole was designed in which a phenyltetrazole moiety was incorporated as a receptor binding equivalent of the triene unit of LTD4.A number of these phenyltetrazoles were prepared and found to possess LTD4 receptor antagonist activity.The structure-activity relationship (SAR) of this series is described.
View MoreWuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Nanjing Samwon International Limited
Contact:+86-25-84873444
Address:1108, BLDG B, New Century Plaza, No 1, South Taiping Rd.,
Ningxia Soochow Agrochemical Limited Company
Contact:(+86）0512 6320 8190
Address:wujiang
Contact:+86-310-7092106
Address:Quzhou Modern & New Industrial Park, Handan, Hebei 057250, China
Doi:10.1002/jhet.825
(2012)Doi:10.1016/S1872-2067(11)60345-8
(2012)Doi:10.1021/ja01878a081
(1939)Doi:10.1016/j.jfluchem.2012.06.003
(2012)Doi:10.1021/ol300297t
(2012)Doi:10.1039/c2cc34144a
(2012)
